| Product Code: ETC5360220 | Publication Date: Nov 2023 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Ravi Bhandari | No. of Pages: 60 | No. of Figures: 30 | No. of Tables: 5 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Latvia Gastrointestinal Diseases Market Overview |
3.1 Latvia Country Macro Economic Indicators |
3.2 Latvia Gastrointestinal Diseases Market Revenues & Volume, 2021 & 2031F |
3.3 Latvia Gastrointestinal Diseases Market - Industry Life Cycle |
3.4 Latvia Gastrointestinal Diseases Market - Porter's Five Forces |
3.5 Latvia Gastrointestinal Diseases Market Revenues & Volume Share, By Drug Type, 2021 & 2031F |
3.6 Latvia Gastrointestinal Diseases Market Revenues & Volume Share, By Dosage Form, 2021 & 2031F |
3.7 Latvia Gastrointestinal Diseases Market Revenues & Volume Share, By Application, 2021 & 2031F |
4 Latvia Gastrointestinal Diseases Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of gastrointestinal diseases in Latvia |
4.2.2 Growing awareness about gastrointestinal health and early diagnosis |
4.2.3 Technological advancements in diagnostic tools and treatment options for gastrointestinal diseases |
4.3 Market Restraints |
4.3.1 Limited access to specialized healthcare services in remote areas of Latvia |
4.3.2 High cost of advanced diagnostic tests and treatment for gastrointestinal diseases |
4.3.3 Lack of skilled healthcare professionals specializing in gastroenterology in Latvia |
5 Latvia Gastrointestinal Diseases Market Trends |
6 Latvia Gastrointestinal Diseases Market Segmentations |
6.1 Latvia Gastrointestinal Diseases Market, By Drug Type |
6.1.1 Overview and Analysis |
6.1.2 Latvia Gastrointestinal Diseases Market Revenues & Volume, By Antacids, 2021-2031F |
6.1.3 Latvia Gastrointestinal Diseases Market Revenues & Volume, By Laxatives, 2021-2031F |
6.1.4 Latvia Gastrointestinal Diseases Market Revenues & Volume, By Antidiarrheal Agents, 2021-2031F |
6.1.5 Latvia Gastrointestinal Diseases Market Revenues & Volume, By Antiemetics, 2021-2031F |
6.1.6 Latvia Gastrointestinal Diseases Market Revenues & Volume, By Antiulcer Agents, 2021-2031F |
6.1.7 Latvia Gastrointestinal Diseases Market Revenues & Volume, By Other, 2021-2031F |
6.2 Latvia Gastrointestinal Diseases Market, By Dosage Form |
6.2.1 Overview and Analysis |
6.2.2 Latvia Gastrointestinal Diseases Market Revenues & Volume, By Oral, 2021-2031F |
6.2.3 Latvia Gastrointestinal Diseases Market Revenues & Volume, By Parenteral, 2021-2031F |
6.2.4 Latvia Gastrointestinal Diseases Market Revenues & Volume, By Other, 2021-2031F |
6.3 Latvia Gastrointestinal Diseases Market, By Application |
6.3.1 Overview and Analysis |
6.3.2 Latvia Gastrointestinal Diseases Market Revenues & Volume, By Ulcerative Colitis, 2021-2031F | 6.3.3 Latvia Gastrointestinal Diseases Market Revenues & Volume, By Irritable Bowel Syndrome, 2021-2031F |
6.3.4 Latvia Gastrointestinal Diseases Market Revenues & Volume, By Crohn Disease, 2021-2031F |
6.3.5 Latvia Gastrointestinal Diseases Market Revenues & Volume, By Celiac Disease, 2021-2031F |
6.3.6 Latvia Gastrointestinal Diseases Market Revenues & Volume, By Gastroenteritis, 2021-2031F |
6.3.7 Latvia Gastrointestinal Diseases Market Revenues & Volume, By Other, 2021-2031F |
7 Latvia Gastrointestinal Diseases Market Import-Export Trade Statistics |
7.1 Latvia Gastrointestinal Diseases Market Export to Major Countries |
7.2 Latvia Gastrointestinal Diseases Market Imports from Major Countries |
8 Latvia Gastrointestinal Diseases Market Key Performance Indicators |
8.1 Average waiting time for gastrointestinal disease diagnosis and treatment |
8.2 Percentage of the population undergoing regular screening for gastrointestinal diseases |
8.3 Adoption rate of new technologies in diagnosing and treating gastrointestinal diseases. |
9 Latvia Gastrointestinal Diseases Market - Opportunity Assessment |
9.1 Latvia Gastrointestinal Diseases Market Opportunity Assessment, By Drug Type, 2021 & 2031F |
9.2 Latvia Gastrointestinal Diseases Market Opportunity Assessment, By Dosage Form, 2021 & 2031F |
9.3 Latvia Gastrointestinal Diseases Market Opportunity Assessment, By Application, 2021 & 2031F |
10 Latvia Gastrointestinal Diseases Market - Competitive Landscape |
10.1 Latvia Gastrointestinal Diseases Market Revenue Share, By Companies, 2024 |
10.2 Latvia Gastrointestinal Diseases Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations | 13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here